BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34044801)

  • 1. Robust expression of LINE-1 retrotransposon encoded proteins in oral squamous cell carcinoma.
    Mukherjee K; Sur D; Singh A; Rai S; Das N; Sekar R; Narindi S; Dhingra VK; Jat B; Balraam KVV; Agarwal SP; Mandal PK
    BMC Cancer; 2021 May; 21(1):628. PubMed ID: 34044801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINE-1 retrotransposon encoded ORF1p expression and promoter methylation in oral squamous cell carcinoma: a pilot study.
    Budania S; Sur D; Nangal J; Pilli S; Mukherjee K; Biswas M; Prasad R; Saxena S; Mandal PK
    Cancer Genet; 2020 Jun; 244():21-29. PubMed ID: 32088612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human LINE-1 retrotransposition requires a metastable coiled coil and a positively charged N-terminus in L1ORF1p.
    Khazina E; Weichenrieder O
    Elife; 2018 Mar; 7():. PubMed ID: 29565245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L1-ORF1p, a Smad4 interaction protein, promotes proliferation of HepG2 cells and tumorigenesis in mice.
    Zhu Y; Feng F; Yu J; Song B; Hu M; Gao X; Wang Y; Zhang Q
    DNA Cell Biol; 2013 Sep; 32(9):531-40. PubMed ID: 23863096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of L1-Ribonucleoprotein Particles (L1-RNPs) from Cultured Human Cells.
    Mandal PK; Kazazian HH
    Methods Mol Biol; 2016; 1400():299-310. PubMed ID: 26895061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-610 functions as a tumor suppressor in oral squamous cell carcinoma by directly targeting AGK.
    Yao LX; Liu J; Xu L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):187-197. PubMed ID: 30657560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00961 suppresses cell proliferation and induces cell apoptosis in oral squamous cell carcinoma.
    Pan LN; Sun YR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3358-3365. PubMed ID: 31081090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-625-3p promotes cell migration of oral squamous cell carcinoma by regulating SCAI expression.
    Xu D; Gu M; Liu HL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):641-648. PubMed ID: 30720172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
    Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
    Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
    Han L; Cheng J; Li A
    Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
    [No Abstract]   [Full Text] [Related]  

  • 11. High expression of Rab31 confers a poor prognosis and enhances cell proliferation and invasion in oral squamous cell carcinoma.
    Li X; Zhu F; Liu Z; Tang X; Han Y; Jiang J; Ma C; He Y
    Oncol Rep; 2021 Mar; 45(3):1182-1192. PubMed ID: 33469675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-373 promotes proliferation and metastasis of oral squamous cell carcinoma by targeting SPOP.
    Zhang XJ; Jin Y; Song JL; Deng F
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5270-5276. PubMed ID: 31298378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of RNase 7 in the malignant potential of oral squamous cell carcinoma cells.
    Neopane P; Kurashige Y; Yoshida K; Uehara O; Paudel D; Morikawa T; Sato J; Saitoh M; Abiko Y
    Oncol Rep; 2020 Sep; 44(3):1216-1223. PubMed ID: 32705284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-127-3p targets KIF3B to inhibit the development of oral squamous cell carcinoma.
    Ji L; Zhu ZN; He CJ; Shen X
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):630-640. PubMed ID: 30720171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly active synthetic mammalian retrotransposon.
    Han JS; Boeke JD
    Nature; 2004 May; 429(6989):314-8. PubMed ID: 15152256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
    Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
    Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of reverse transcriptase inhibitors on LINE-1 and Ty1 reverse transcriptase activities and on LINE-1 retrotransposition.
    Dai L; Huang Q; Boeke JD
    BMC Biochem; 2011 May; 12():18. PubMed ID: 21545744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathobiological role of cleft palate transmembrane protein 1 family proteins in oral squamous cell carcinoma.
    Inoue K; Hatano K; Hanamatsu Y; Saigo C; Kito Y; Bunai K; Shibata T; Takeuchi T
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):851-859. PubMed ID: 30635792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Scanning Mutagenesis of Human Retrotransposon LINE-1 Identifies Motifs Essential for Function.
    Adney EM; Ochmann MT; Sil S; Truong DM; Mita P; Wang X; Kahler DJ; Fenyö D; Holt LJ; Boeke JD
    Genetics; 2019 Dec; 213(4):1401-1414. PubMed ID: 31666291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
    Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.